Valeur202020212022202320242025Total du passif445.92 M583.18 M688.73 M676.37 M465.31 M685.93 MTotal des capitaux propres486.24 M653.3 M705.74 M765.33 M1.2 B1.71 BTotal du passif et des capitaux propres932.15 M1.24 B1.39 B1.44 B1.66 B2.4 BDette totale252.55 M330.45 M362 M363.35 M——Dette nette-484.73 M-583.84 M-536.3 M126.47 M——
Natera, Inc. - Common Stock
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.